Surgeons Perform the First Partial Face Transplant

In Brief

Surgeons in Amiens, France, performed the first partial face transplant on November 27, 2005. The operation reconstructed part of a severely injured patient's face using donor tissue. The procedure brought together surgery, transplantation medicine, rehabilitation and complex ethical questions. It depended on a donor and the donor family's decision as well as the surgical team. The first partial transplant should not be called the first full face transplant.

A Partial Transplant in Amiens

On November 27, 2005, a French team performed the first successful partial face transplant in Amiens. Isabelle Dinoire had suffered severe injury to the central part of her face. The operation transplanted living tissue that included the nose, lips and chin from a deceased donor. This was not a full-face transplant, and its purpose went beyond changing appearance. The injured structures are important for ordinary functions such as eating and speech. The operation aimed to restore some of those functions using tissue capable of bringing structures together in ways that conventional reconstruction could not fully achieve in this case.

More Than Replacing Skin

The procedure involved connecting blood vessels to keep the tissue alive and dealing with nerves and muscles important to movement and sensation. Those systems did not resume every function immediately. Recovery required time, medical follow-up and rehabilitation. Transplanted tissue also brings a risk of rejection, requiring immunosuppressive medication and monitoring. A technically successful operation therefore creates a continuing medical responsibility. It is not equivalent to a finished result at the moment the patient leaves the operating room. Much of the evidence for success comes from what the person is able to do later and from the ability to manage complications.

Why the Ethical Questions Were Distinct

Face transplantation prompted debate because of the balance between improvements in function and the risks of long-term treatment. Consent, donor anonymity and public attention also mattered. A person's face participates in communication and social identity in ways different from many internal organs. That does not mean a recipient simply acquires the donor's appearance or identity. Underlying anatomy, healing and individual expression all affect the outcome. Ethical discussion was most useful when it asked what benefit was possible for a particular patient and what burdens could reasonably accompany it.

The Case Was a Beginning, Not a Universal Treatment

The operation showed that such a transplant could be performed and followed clinically. Later teams developed the field through different procedures and patient selection. The first case did not establish that transplantation would be appropriate for every severe facial injury, nor that recovery would be predictable. Its significance lies in making a treatment possible under specific conditions and giving clinicians evidence to assess where it might help. November 27 identifies the operation; the longer history includes care, function, complications and the patient's own experience of living with the result.